Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-018319
Filing Date
2024-05-24
Accepted
2024-05-24 16:01:48
Documents
6
Effectiveness Date
2024-05-24
Reference 429
333-266789

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dmtp20240521_s8.htm S-8 62696
2 EXHIBIT 5.1 ex_678075.htm EX-5.1 12731
3 EXHIBIT 23.1 ex_678076.htm EX-23.1 2473
4 EXHIBIT FILING FEES ex_678077.htm EX-FILING FEES 26055
5 d2.jpg GRAPHIC 1811
6 dmac.jpg GRAPHIC 9176
  Complete submission text file 0001437749-24-018319.txt   120516
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279710 | Film No.: 24984133
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)